Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 4, 2008
Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial
Hong-nü Chu, Mei-juan Shen
Therapeutics and Clinical Risk Management 2008, 4:287-290
Published Date: 8 February 2008
Factors affecting therapeutic compliance: A review from the patient’s perspective
Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li
Therapeutics and Clinical Risk Management 2008, 4:269-286
Published Date: 8 February 2008
Zoledronic acid in the management of metastatic bone disease
Thomas J Polascik, Vladimir Mouraviev
Therapeutics and Clinical Risk Management 2008, 4:261-268
Published Date: 8 February 2008
Cannabinoids in the management of difficult to treat pain
Ethan B Russo
Therapeutics and Clinical Risk Management 2008, 4:245-259
Published Date: 8 February 2008
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
Lala M Dunbar, Derek M Tang, Robert M Manausa
Therapeutics and Clinical Risk Management 2008, 4:235-244
Published Date: 8 February 2008
Management of laryngopharyngeal reflux with proton pump inhibitors
Christina Reimer, Peter Bytzer
Therapeutics and Clinical Risk Management 2008, 4:225-233
Published Date: 8 February 2008
Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
Marcello Ciaccio, Giulia Bivona, Chiara Bellia
Therapeutics and Clinical Risk Management 2008, 4:219-224
Published Date: 8 February 2008
A review of topotecan in combination chemotherapy for advanced cervical cancer
Minoo Robati, David Holtz, Charles J Dunton
Therapeutics and Clinical Risk Management 2008, 4:213-218
Published Date: 8 February 2008
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
Ranjit K Goudar
Therapeutics and Clinical Risk Management 2008, 4:205-211
Published Date: 8 February 2008
Long-term safety of aromatase inhibitors in the treatment of breast cancer
Jean-Marc A Nabholtz
Therapeutics and Clinical Risk Management 2008, 4:189-204
Published Date: 8 February 2008
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Martin Henkes, Heiko van der Kuip, Walter E Aulitzky
Therapeutics and Clinical Risk Management 2008, 4:163-187
Published Date: 8 February 2008
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
Omar S Din, Penella J Woll
Therapeutics and Clinical Risk Management 2008, 4:149-162
Published Date: 8 February 2008
Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
Efstratios Vakirlis, Athanasios Kastanis, Demetrios Ioannides
Therapeutics and Clinical Risk Management 2008, 4:141-148
Published Date: 8 February 2008
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
Putao Cen, Eric D Tetzlaff, Jaffer A Ajani
Therapeutics and Clinical Risk Management 2008, 4:137-140
Published Date: 8 February 2008
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
Teru Hideshima, Noopur Raje, Paul G Richardson, Kenneth C Anderson
Therapeutics and Clinical Risk Management 2008, 4:129-136
Published Date: 8 February 2008
A review of solifenacin in the treatment of urinary incontinence
Ramandeep Basra, Con Kelleher
Therapeutics and Clinical Risk Management 2008, 4:117-128
Published Date: 8 February 2008
Trabectedin and its potential in the treatment of soft tissue sarcoma
Philippe A Cassier, Armelle Dufresne, Jean-Yves Blay, Jérôme Fayette
Therapeutics and Clinical Risk Management 2008, 4:109-116
Published Date: 8 February 2008
A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
Mark A Ware, Paul Daeninck, Vincent Maida
Therapeutics and Clinical Risk Management 2008, 4:99-107
Published Date: 8 February 2008
Advances in the use of topical imiquimod to treat dermatologic disorders
Francesco Lacarrubba, Maria Rita Nasca, Giuseppe Micali
Therapeutics and Clinical Risk Management 2008, 4:87-97
Published Date: 8 February 2008
Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
Robert A Bok
Therapeutics and Clinical Risk Management 2008, 4:79-85
Published Date: 8 February 2008
Anidulafungin in the treatment of invasive fungal infections
Kathryn Sabol, Tawanda Gumbo
Therapeutics and Clinical Risk Management 2008, 4:71-78
Published Date: 8 February 2008
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
Vandana A Govan
Therapeutics and Clinical Risk Management 2008, 4:65-70
Published Date: 8 February 2008
Why does the world need another rotavirus vaccine?
Richard L Ward, Monica M McNeal, A Duncan Steele
Therapeutics and Clinical Risk Management 2008, 4:49-63
Published Date: 8 February 2008
Serotonin receptor modulators in the treatment of irritable bowel syndrome
Mohammad Fayyaz, Jeffrey M Lackner
Therapeutics and Clinical Risk Management 2008, 4:41-48
Published Date: 8 February 2008
Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
Jason W Bennett, James S Lewis II, Michael W Ellis
Therapeutics and Clinical Risk Management 2008, 4:31-40
Published Date: 8 February 2008
Critical appraisal of medical devices in the management of cerebrovascular disease
Michael J Schneck
Therapeutics and Clinical Risk Management 2008, 4:19-29
Published Date: 8 February 2008
Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy
Mischel G Neill, Rohan Shahani, Alexandre R Zlotta
Therapeutics and Clinical Risk Management 2008, 4:11-18
Published Date: 8 February 2008
Review of photodynamic therapy in actinic keratosis and basal cell carcinoma
Marica B Ericson, Ann-Marie Wennberg, Olle Larkö
Therapeutics and Clinical Risk Management 2008, 4:1-9
Published Date: 8 February 2008
Editorial ||FREE PAPER||
Garry M Walsh
Therapeutics and Clinical Risk Management 2008, 4:0-0
Published Date: 8 February 2008